Catalysis, Unichem partner to launch VIUSID


Catalysis, a healthcare company based in Spain has partnered with pharmaceutical marketing and distribution firm, Unichem to launch one of the world’s most potent antioxidants “VIUSID” onto the Ghanaian market.

VIUSID is a food supplement designed to promote the body’s organic functions and works on strengthening the immune system.

The manufacturers use “Molecular Activation Technology” which enhances the antioxidant capacity and efficacy of the product by at least 1000x, thereby providing antiviral, antioxidant and anti-free radical function that can comfort and heal even in the most adverse conditions.

Research expert with the Catalysis group, Dr. Marouane Boutami commenting on the introduction of the product to the Ghanaian market said: “We are very proud to release this breakthrough product onto the Ghanaian market.

“The COVID-pandemic is one of the most significant health and social crisis in the last 100 years. But there are still over 1.6 million unknown viruses out there & none of them function in the same manner.

Viusid has shown excellent results in clinical trials not only in the most common infectious diseases but even in case of hepatitis, cancer, malaria and AIDS.”

Senior Pharmacist with Unichem, Basil Akussah said: “We are very proud to bring such a potent and globally recognized product onto the Ghanaian market which even has studies published by the British Medical Journal”.

Viusid is a food supplement safe to take over longer periods and suitable for both adults and children. It is good for cold or flu; it has shown excellent results in raising the body’s immunity.

Catalysis along with Unichem would this month also launch Renalof , a product which supports patients with urinary tract conditions as well as Spermotrend which helps against male infertility  and Diamel, which is used to treat type 2 diabetes.


Leave a Reply